The competition in genera is almost exclusively a competition over price. That puts enormous pressure on the inspection and certification process to be thorough. We need to create a system that provides not only confidence for the users, but actually fearing concern from all the producers as well.
Iran’s protests may have gone quiet for the moment, but that does not mean they’ve been defeated. Beneath a calmer surface, Iranians are seething and biding their time. India’s pharma sector is huge, but has long been dogged by concerns about quality control. And we reveal last year’s most newsworthy subject.
For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/intelligenceoffer